ADC Therapeutics SA Basic Earnings Loss Per Share
ADC Therapeutics SA (ADCT) reported Basic Earnings Loss Per Share of -$0.58 per share for the 3-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShare · last filed 2023-11-07
- ADC Therapeutics SA basic earnings loss per share for the quarter ending 2023-09-30 was -$0.58.
- ADC Therapeutics SA basic earnings loss per share for the quarter ending 2023-06-30 was -$0.58.
- ADC Therapeutics SA basic earnings loss per share for the quarter ending 2023-03-31 was -$0.74.
- ADC Therapeutics SA basic earnings loss per share for the quarter ending 2022-09-30 was -$0.65.
| Period end | Basic Earnings Loss Per Share 3 month | Basic Earnings Loss Per Share 6 month | Basic Earnings Loss Per Share 9 month |
|---|---|---|---|
| 2023-09-30 | -$0.58 6-K · filed 2023-11-07 | -$1.89 6-K · filed 2023-11-07 | |
| 2023-06-30 | -$0.58 6-K · filed 2023-08-08 | -$1.31 6-K · filed 2023-08-08 | |
| 2023-03-31 | -$0.74 6-K · filed 2023-05-09 | ||
| 2022-09-30 | -$0.65 6-K · filed 2023-11-07 | -$1.70 6-K · filed 2023-11-07 | |
| 2022-06-30 | -$0.84 6-K · filed 2023-08-08 | -$1.05 6-K · filed 2023-08-08 | |
| 2022-03-31 | -$0.22 6-K · filed 2023-05-09 | ||
| 2021-09-30 | -$0.93 6-K · filed 2022-11-08 | -$2.55 6-K · filed 2022-11-08 | |
| 2021-06-30 | -$0.95 6-K · filed 2022-08-09 | -$1.62 6-K · filed 2022-08-09 | |
| 2021-03-31 | -$0.67 6-K · filed 2022-05-09 | ||
| 2020-09-30 | -$0.29 6-K · filed 2021-11-02 | -$3.09 6-K · filed 2021-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |